FasL gene therapy: a new therapeutic modality for head and neck cancer. - Wikidata - awgldk - TriplyDB

FasL gene therapy: a new therapeutic modality for head and neck cancer.

FasL gene therapy: a new therapeutic modality for head and neck cancer.

http://www.wikidata.org/entity/Q40303364

about

Role of CXC chemokine ligand 13 in oral squamous cell carcinoma associated osteolysis in athymic mice.Targeting Fas in osteoresorptive disorders.Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.Identifying fragilities in biochemical networks: robust performance analysis of Fas signaling-induced apoptosis.The Del1 deposition domain can immobilize 3alpha-hydroxysteroid dehydrogenase in the extracellular matrix without interfering with enzymatic activity Mononuclear phagocytes in head and neck squamous cell carcinoma.Survival signalling and apoptosis resistance in glioblastomas: opportunities for targeted therapeutics.Potential for modulation of the fas apoptotic pathway by epidermal growth factor in sarcomas.Efficient nonviral gene therapy with FasL and Del1 fragments in mice.Efficient growth suppression and apoptosis in human laryngeal carcinoma cell line HEP-2 induced by an adeno-associated virus expressing human FAS ligand.A novel dual signaling axis for NSP 5a3a induced apoptosis in head and neck carcinoma.Fas ligand gene transfer effectively induces apoptosis in head and neck cancer cells.Targeted nonviral gene therapy in prostate cancer

P2860

Q33759518-16D04419-886B-4823-AFD6-CEEBA63EB850 Q34561691-61058B84-93AB-4391-BE0A-07878A63A5F2 Q36804432-D476A5E4-CD0C-4A58-A637-50D6737E9141 Q36856453-9AD88B49-FD51-484F-B229-725194F84414 Q37271629-E436A219-21EE-442C-B465-305FC08F4A09 Q37646333-45810D53-72A8-4F0D-A977-B25A3B697B82 Q37761935-6EC44E57-FC05-4C4B-AD56-466A2B40E0D3 Q38909468-DFD89181-0EE6-482E-A1AC-36CAEB811D12 Q39247938-22C7DA1C-3B5E-4226-A458-7D5DD8758983 Q39408042-E366B80A-5EB5-406A-B651-57CA774BF5A6 Q39428299-FE33A908-8FAF-4ADB-B231-F08B53C9A9AC Q39556274-249FFF08-92BA-441C-9A39-BC1DFDBA2AD4 Q57492228-5386A84D-5676-4ED1-9034-3C9D60F83BF0

P2860

FasL gene therapy: a new therapeutic modality for head and neck cancer.

http://www.wikidata.org/entity/Q40303364

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

FasL gene therapy: a new therapeutic modality for head and neck cancer.

@en

type

label

FasL gene therapy: a new therapeutic modality for head and neck cancer.

@en

prefLabel

FasL gene therapy: a new therapeutic modality for head and neck cancer.

@en

P1433

Q40303364-4F773A0F-FCF4-4C2C-94B9-12AC98A8BD05

P1476

Q40303364-42F48A8C-7014-43F3-BD67-DFE0D811403C

P2093

Q40303364-01AFD1F9-8829-4584-8AE5-318DC7C83110

Q40303364-0AC83A66-9680-420C-9E91-9EF26D83F030

Q40303364-11EF787F-5E08-42A3-81A7-6CBF3023D366

Q40303364-3DFAB3F1-DFFF-4090-AB84-575C3B5E635A

Q40303364-411E473B-27E2-46A6-A725-8CA543BB3AC5

Q40303364-52E826DC-6282-49BF-A4C4-3B471208F34F

Q40303364-9049DA3A-99B8-4604-860D-4E3B309C7AD8

Q40303364-9F2AB1D0-4268-4097-8C9A-72B193B79259

Q40303364-CEBB8E79-CD50-41BB-BAD0-BC658CD140EC

P2860

Q40303364-0111B80A-773C-4868-82EF-CE4A12691335

Q40303364-0DCA0499-63CE-4CC7-B70D-C5F0FDB9CF22

Q40303364-126631F7-2120-43DC-A442-FBEC84D9628A

Q40303364-27C74C27-496D-4B01-8A5A-6ADA4B8642C0

Q40303364-6654208C-1DC8-4653-B015-F3C6D8A683F0

Q40303364-807300EC-33DB-4119-B7F6-5936483BD765

Q40303364-831E46D7-71A2-47C9-B92E-C77B4B17EAA3

Q40303364-84A5E9D5-36D3-45D3-AFE8-3F3991AE8532

Q40303364-8C7D9976-DBAE-481D-BD98-9043316083A4

Q40303364-95F05CFF-C1E4-4D66-BF3F-EDE467733409

P2888

Q40303364-7F9130E8-4893-4717-A9B3-2681712F3661

P304

Q40303364-D0BD9B44-1CD6-4CE9-A5C5-9DEEFFBEC419

P31

Q40303364-8F07B88D-AC72-4D78-B677-82FDD7C3D896

P356

Q40303364-98B3D8B5-B8AE-498C-9699-201CE0E06422

P433

Q40303364-CA358832-3020-4551-9369-E83B0FD97C6A

P478

Q40303364-68CCE29A-5B09-47D7-82EE-0F184068F68F

P577

Q40303364-DC241835-5BFA-4291-8C36-B7CCD66936EC

P5875

Q40303364-039332B4-8DAD-4079-B723-FA307329DFE3

P6179

Q40303364-E3E14B93-EA60-4347-A031-001F76931B14

P698

Q40303364-8D9ACFB4-1F86-4301-BBB4-F547384E829A

P921

Q40303364-33538349-1465-470E-9A49-E4FA951E9026

P356

P1433

Cancer Gene Therapy

P1476

FasL gene therapy: a new therapeutic modality for head and neck cancer.

@en

P2093

Day TA

http://www.w3.org/2001/XMLSchema#string

Dong JY

http://www.w3.org/2001/XMLSchema#string

El-Zawahry AM

http://www.w3.org/2001/XMLSchema#string

ElOjeimy S

http://www.w3.org/2001/XMLSchema#string

Holman DH

http://www.w3.org/2001/XMLSchema#string

Liu X

http://www.w3.org/2001/XMLSchema#string

McKillop JC

http://www.w3.org/2001/XMLSchema#string

Norris JS

http://www.w3.org/2001/XMLSchema#string

Schwartz DA

http://www.w3.org/2001/XMLSchema#string

P2860

Human Fas ligand: gene structure, chromosomal location and species specificity

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

Oral cancer treatment.

Progress in head and neck cancer immunotherapy: can tolerance and immune suppression be reversed?

Chemoradiation after surgery for high-risk head and neck cancer patients: how strong is the evidence?

Purification and characterization of the Fas-ligand that induces apoptosis.

Quantification and characterization of the bystander effect in prostate cancer cells following adenovirus-mediated FasL expression.

Downregulation of c-FLIP sensitizes DU145 prostate cancer cells to Fas-mediated apoptosis.

Construction, purification and characterization of adenovirus vectors expressing apoptosis-inducing transgenes.

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells.

P2888

P304

739-745

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.CGT.7700951

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7234781

http://www.w3.org/2001/XMLSchema#string

P6179

1018707588

http://www.w3.org/2001/XMLSchema#string

P698

16543918

http://www.w3.org/2001/XMLSchema#string

P921